Effect of five novel 5-substituted tetrandrine derivatives on P-glycoprotein-mediated inhibition and transport in Caco-2 cells.
暂无分享,去创建一个
Dan Li | Zhonglian Cao | Ping Yang | Li Liu
[1] M. Wink,et al. Tetrandrine and fangchinoline, bisbenzylisoquinoline alkaloids from Stephania tetrandra can reverse multidrug resistance by inhibiting P-glycoprotein activity in multidrug resistant human cancer cells. , 2014, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[2] P. Johnston,et al. Cancer drug resistance: an evolving paradigm , 2013, Nature Reviews Cancer.
[3] Y. Shitara,et al. Potential P-glycoprotein-mediated drug-drug interactions of antimalarial agents in Caco-2 cells. , 2012, The American journal of tropical medicine and hygiene.
[4] J. Iqbal,et al. Design and in vitro evaluation of a novel polymeric P-glycoprotein (P-gp) inhibitor. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[5] R. Mumper,et al. Nanomedicinal strategies to treat multidrug-resistant tumors: current progress. , 2010, Nanomedicine.
[6] L. Lou,et al. ZD6474 reverses multidrug resistance by directly inhibiting the function of P-glycoprotein , 2007, British Journal of Cancer.
[7] A. Bernkop‐Schnürch,et al. In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan. , 2006, Biomaterials.
[8] T. Fuchigami,et al. Electrolytic partial fluorination of organic compounds. 83. Anodic fluorination of N-substituted pyrroles and its synthetic applications to gem-difluorinated heterocyclic compounds. , 2006, Journal of Organic Chemistry.
[9] M. Reinisalo,et al. Absorption properties and P-glycoprotein activity of modified Caco-2 cell lines. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[10] C. Choi,et al. ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal , 2005, Cancer Cell International.
[11] R. V. van Breemen,et al. Caco-2 cell permeability assays to measure drug absorption , 2005, Expert opinion on drug metabolism & toxicology.
[12] W. Fan,et al. In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel. , 2005, Anticancer research.
[13] R. Borchardt,et al. Bidirectional transport of rhodamine 123 and Hoechst 33342, fluorescence probes of the binding sites on P-glycoprotein, across MDCK-MDR1 cell monolayers. , 2004, Journal of pharmaceutical sciences.
[14] Yu-Jen Chen. Potential role of tetrandrine in cancer therapy. , 2002, Acta pharmacologica Sinica.
[15] K. Luthman,et al. Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs. , 1999, The Journal of pharmacology and experimental therapeutics.
[16] P Langguth,et al. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein. , 1999, Journal of pharmaceutical sciences.
[17] P. Artursson,et al. Interplay Between CYP3A-Mediated Metabolism and Polarized Efflux of Terfenadine and Its Metabolites in Intestinal Epithelial Caco-2 (TC7) Cell Monolayers , 1999, Pharmaceutical Research.
[18] Y Zhang,et al. Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics. , 1998, Journal of pharmaceutical sciences.
[19] Shiyin Yee,et al. In Vitro Permeability Across Caco-2 Cells (Colonic) Can Predict In Vivo (Small Intestinal) Absorption in Man—Fact or Myth , 1997, Pharmaceutical Research.
[20] W. Rubas,et al. Flux measurements across Caco-2 monolayers may predict transport in human large intestinal tissue. , 1996, Journal of pharmaceutical sciences.
[21] Y. Canitrot,et al. [Use of rhodamine 123 for the detection of multidrug resistance]. , 1995, Bulletin du cancer.
[22] H. Grunicke,et al. Rapid functional assay for the detection of multidrug-resistant cells using the fluorescent dye rhodamine 123. , 1991, Blood.
[23] P. Artursson,et al. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.
[24] P. Artursson,et al. Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. , 1990, Journal of pharmaceutical sciences.
[25] Thomas J. Raub,et al. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. , 1989, Gastroenterology.
[26] T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.
[27] S. Ambudkar,et al. Saracatinib (AZD0530) is a potent modulator of ABCB1‐mediated multidrug resistance in vitro and in vivo , 2013, International journal of cancer.
[28] J. Tolan,et al. MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening. , 1999, Journal of pharmaceutical sciences.
[29] P. Twentyman,et al. A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes. , 1994, European journal of cancer.
[30] P. Artursson. Cell cultures as models for drug absorption across the intestinal mucosa. , 1991, Critical reviews in therapeutic drug carrier systems.